Based on the results, the LZTR1 expression in tumor tissues appears to be lower in breast invasive carcinoma (BRCA), ovarian serous cystadenocarcinoma (OV), testicular germ call tumors (TGCT), and uterine carcinosarcoma (UCS) (Figure 1(b)P < 0.05). Here, LZTR1 is linked to ovarian serous cystadenocarcinoma.